Researchers Find Gene That Can Regulate Prostate Cancer Development

Recent results from Icahn School of Medicine at Mount Sinai researchers have shown that two approved cancer drugs have the capacity to turn on a gene responsible for cancer cells’ dormancy. In the study entitled, “NR2F1 controls tumor cell dormancy via ​SOX9- and ​RARβ-driven quiescence programmes,” published in Nature Communications, the research team found that